Homéostasie du fer et maladie de Parkinson

Annales de Biologie Clinique

Volumn 56, Issue SPEC. ISS. 2, 1998, Pages 23-30

  Faucheux, B A ^a   Hirsch, E C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; DOPAMINE; FERRITIN; FREE RADICAL; IRON; LACTOFERRIN; LACTOFERRIN RECEPTORS; TRANSFERRIN RECEPTOR;

ANIMAL; COMPARATIVE STUDY; HOMEOSTASIS; HUMAN; METABOLISM; NERVE CELL; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REVIEW; SUBSTANTIA NIGRA;

ANIMALS; DOPAMINE; FERRITINS; FREE RADICALS; HOMEOSTASIS; HUMANS; IRON; LACTOFERRIN; NEURONS; OXIDATIVE STRESS; PARKINSON DISEASE; RATS; RECEPTORS, CELL SURFACE; RECEPTORS, TRANSFERRIN; SUBSTANTIA NIGRA;

EID: 0342598367     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Agid Y. Parkinson's disease: pathophysiology. Lancet 1991 ; 337 : 1321-4.
2. Olanow CW. A radical hypothesis for neurodegeneration. Trends Neurosci 1993; 16 : 439-44.
3. Jenner P. Oxidative damage in neurodegenerative disease. Lancet 1994 ; 344: 796-8.
4. Hirsch EC, Graybiel AM, Agid Y. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 1988 ; 334 : 345-8.
5. Damier P, Agid Y, Hirsch EC, Graybiel A. Temporospatial progression of the loss of dopaminergic neurons in the substantia nigra in Parkinson's disease. 12th International Symposium on Parkinson's disease. London, March 23-26, 1997. Mov Disorders 1997 ; 12 : 73.
6. Ruberg M, France-Lanord V, Brugg B, et al. La mort neuronale par apoptose dans la maladie de Parkinson. Rev Neural 1997 ; 153 : 499-508.
7. Agid Y, Ruberg M, Javoy-Agid F, et al. Are dopaminergic neurons selectively vulnerable to Parkinson's disease ? Adv Neurol 1993 ; 60 : 148-64.
8. Ruberg M, France-Lanord V, Brugg B, et al. Parkinson's disease, apoptosis and oxidative stress. In : Montagnier L, Olivier R, Pasquier C. Oxidative stress and redox regulation. New York, Marcel Dekker, 1997 : 473-87.
9. Graham DG. On the origin and significance of neuromelanin. Arch Pathol Lab Med 1979 ; 103 : 359-62.
10. Damier P, Kastner A, Agid Y, Hirsch E. Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease ? Neurology 1997 ; 46 : 1262-9.
11. Zhang P, Damier P, Hirsch EC, et al. Preferential expression of superoxide dismutase messenger RNA in melanized neurons in human mesencephalon - with reference to Parkinson's disease. Neuroscience 1993 ; 55 : 167-75.
12. Damier P, Hirsch EC, Zhang P, Agid YA, Javoy-Agid F. Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience 1993 ; 52 : 1-6.
13. Yamada T, McGeer PL, Baimbridge KG, McGeer P. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin D28K. Brain Res 1990 ; 52 : 303-7.
14. Hirsch EC, Mouatt A, Thomasset M, Javoy-Agid F, Agid Y, Graybiel AM. Expression of calbindin D28K-like immunoreactivity in catecholaminergic cell groups of the human midbrain : normal distribution and distribution in Parkinson's disease. Neurodegeneration 1992 ; 1 : 83-93.
15. Dexter DT, Carter CJ, Wells FR, et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 1989 ; 52 : 1830-6.
16. Dexter DT, Holley AE, Flitter WD, et al. Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra : an HPLC and ESR study. Mov Disorders 1994 ; 9 : 92-7.
17. Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y. Immunohistochemical detection of 4-hydroxynoneal protein adducts in Parkinson disease. Proc Natl Acad Sci USA 1996 ; 93 : 2696-701.
18. Alam ZI, Jenner A, Daniel SE, et al. Oxidative DNA damage in the parkinsonian brain : an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem 1997 ; 69 : 1196-203.
19. Alam ZI, Daniel SE, Lees AJ, Marsden CD, Jenner P, Halliwell B. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J Neurochem 1997 ; 69 : 1326-9.
20. Zhang Y, Marcillat O, Giulivi C, Ernster L, Davies KJA. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem 1990 ; 265 : 16330-6.
21. Sian J, Dexter DT, Lees AJ, et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 1994 ; 36 : 348-55.
22. Earle KM. Studies on Parkinson's disease including X-ray fluorescent spectroscopy of formalin fixed brain tissue. J Neuropathol Exp Neurol 1968 ; 27 : 1-14.
23. Dexter DT, Wells FR, Agid F, Lees AJ, Jenner P, Marsden CD. Increased nigral iron content in post-mortem parkinsonian brain. Lancet 1987 ; 2 : 1219-20.
24. Dexter DT, Wells FR, Agid F, et al. Increased iron nigral content and alteration in other metals occuring in Parkinson's disease. J Neurochem 1989 ; 52 : 1830-6.
25. Dexter DT, Carayon A, Javoy-Agid F, et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other degenerative diseases affecting the basal ganglia. Brain 1991 ; 114 : 1953-75.
26. Sofic E, Riederer P, Heinsen H, et al. Increased iron (III) and total iron content in post-mortem substantia nigra of parkinsonian brain. J Neural Transm 1988 ; 74 : 199-205.
27. Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MBH. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 1991 ; 56 : 978-82.
28. Riederer P, Sofic EM, Rausch WD, et al. Transition metals, ferritin, glutathione and ascorbic acid in parkinsonian brains. J Neurochem 1989 ; 52 : 515-20.
29. Riederer P, Dirr A, Goetz M, Sofie E, Jellinger K, Youdim MBH. Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease. Ann Neural 1992 ; 32 : S101-4.
30. Hirsch EC, Brandel JP, Galle P, Agid Y. Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease : an x-ray microanalysis. J Neurochem 1991 ; 56 : 446-51.
31. Good PF, Olanow CW, Perl DP. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminium in Parkinson's disease : a LAMMA study. Brain Res 1992 ; 593 : 343-6.
32. Jellinger K, Kienzl E, Rumpelmair G, et al. Iron-melanin complex in substantia nigra of parkinsonian brains : an x-ray microanalysis. J Neurochem 1992 ; 59 : 1168-71.
33. Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochein 1958 ; 3 : 41-51.
34. Dwork AJ, Schon EA, Herbert J. Nonidentical distribution of transferrin and ferric iron in human brain. Neuroscience 1998 ; 27 : 333-45.
35. Nagatsu T. Tyrosine hydroxylase : human isoforms, structure and regulation in physiology and pathology. Essays Biochem 1995 ; 30 : 15-35.